Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Iron
Lexon (UK) Ltd
B03AC
Iron
50 milligram(s)
Solution for injection/infusion
Product subject to prescription which may not be renewed (A)
Iron, parenteral preparations
Authorised
2018-02-09
PACKAGE LEAFLET: INFORMATION FOR THE USER COSMOFER 50MG/ML SOLUTION FOR INFUSION AND INJECTION ® Ref: 1097/034/001/151117/1/F ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU * Keep this leaflet. You may need to read it again. * If you have any further questions, ask your doctor or nurse. * If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or nurse. WHAT IS IN THIS LEAFLET What CosmoFer is and what it is used for What you need to know before you receive CosmoFer How CosmoFer is given Possible side effects How to store CosmoFer Content of the pack and other information WHAT COSMOFER IS AND WHAT IT IS USED FOR CosmoFer contains a combination of iron and dextran (a long chain of sugar molecules). The type of iron in CosmoFer is the same as that found naturally in the body called ‘ferritin’. This means that you can have CosmoFer by injection in high doses. CosmoFer is used for low levels of iron (sometimes called ‘iron deficiency’) if: * you cannot take iron by mouth, for example you cannot tolerate it * you have taken iron by mouth and it has not worked * your doctor decides you need iron very quickly to build up your iron stores. WHAT YOU NEED TO KNOW BEFORE YOU RECEIVE COSMOFER YOU MUST NOT RECEIVE COSMOFER: * if you are allergic (hypersensitive) to the product or any of the other ingredients of this medicine (listed in section 6) * if you have experienced serious allergic (hypersensitive) reactions to other injectable iron preparations * if you have anaemia that is not caused by low levels of iron (deficiency), such as ‘haemolytic’ anaemia * if you have too much iron (overload) or a problem in the way your body uses iron * if Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1 NAME OF THE MEDICINAL PRODUCT CosmoFer 50mg/ml solution for infusion and injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 2 ml ampoule containing 100 mg iron (III) as Iron (III)-hydroxide dextran complex Each ml contains 50 mg Iron (III). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion and injection _Product imported from Greece_ A dark brown solution. 4 CLINICAL PARTICULARS As per PA0982/001/001 5 PHARMACOLOGICAL PROPERTIES As per PA0982/001/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Water for injections Sodium hydroxide (pH adjuster) Hydrochloric acid (pH adjuster) 6.2 INCOMPATIBILITIES This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. 6.3 SHELF LIFE The shelf life expiry date for this product shall be the date shown on the ampoules and outer package of the product on the market in the country of origin. From a microbiological point of view, the product should be used immediately after opening of the container. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _2_ _/_ _0_ _2_ _/_ _2_ _0_ _1_ _8_ _C_ _R_ _N_ _ _ _2_ _1_ _9_ _8_ _3_ _1_ _5_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ Read the complete document